vs
Fastenal（FAST）与Solventum（SOLV）财务数据对比。点击上方公司名可切换其他公司
Fastenal的季度营收约是Solventum的1.0倍（$2.0B vs $2.0B），Fastenal净利率更高（14.5% vs 3.2%，领先11.3%），Fastenal同比增速更快（3.5% vs -3.7%），Fastenal自由现金流更多（$308.2M vs $32.0M），过去两年Fastenal的营收复合增速更高（2.9% vs -0.4%）
Fastenal是1967年成立的美国上市企业，总部位于明尼苏达州威诺纳，是北美最大的紧固件分销商，同时也是工业和建筑用品的主流供应商，可提供货柜备货、智能售货柜、库存管理、物流配送等一站式供应链解决方案。
Solventum是一家总部位于美国的医疗健康企业，于2024年4月1日正式从全球知名多元化工业集团3M分拆后独立运营，继承了原3M旗下医疗板块的技术积累与业务资源，面向全球市场提供专业医疗相关产品及服务。
FAST vs SOLV — 直观对比
营收规模更大
FAST
是对方的1.0倍
$2.0B
营收增速更快
FAST
高出7.2%
-3.7%
净利率更高
FAST
高出11.3%
3.2%
自由现金流更多
FAST
多$276.2M
$32.0M
两年增速更快
FAST
近两年复合增速
-0.4%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $2.0B | $2.0B |
| 净利润 | $293.9M | $63.0M |
| 毛利率 | 44.3% | 51.4% |
| 营业利润率 | 18.9% | 6.3% |
| 净利率 | 14.5% | 3.2% |
| 营收同比 | 3.5% | -3.7% |
| 净利润同比 | -1.6% | 103.2% |
| 每股收益（稀释后） | $-0.01 | $0.37 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FASTSOLV
| Q1 26 | $2.0B | — | ||
| Q4 25 | $2.0B | $2.0B | ||
| Q3 25 | $2.1B | $2.1B | ||
| Q2 25 | $2.1B | $2.2B | ||
| Q1 25 | $2.0B | $2.1B | ||
| Q4 24 | $1.8B | $2.1B | ||
| Q3 24 | $1.9B | $2.1B | ||
| Q2 24 | $1.9B | $2.1B |
净利润FASTSOLV
| Q1 26 | $293.9M | — | ||
| Q4 25 | $293.9M | $63.0M | ||
| Q3 25 | $335.5M | $1.3B | ||
| Q2 25 | $330.3M | $90.0M | ||
| Q1 25 | $298.7M | $137.0M | ||
| Q4 24 | $262.1M | $31.0M | ||
| Q3 24 | $298.1M | $122.0M | ||
| Q2 24 | $292.7M | $89.0M |
毛利率FASTSOLV
| Q1 26 | 44.3% | — | ||
| Q4 25 | 44.3% | 51.4% | ||
| Q3 25 | 45.3% | 54.2% | ||
| Q2 25 | 45.3% | 54.4% | ||
| Q1 25 | 45.1% | 53.8% | ||
| Q4 24 | 44.8% | 53.9% | ||
| Q3 24 | 44.9% | 56.0% | ||
| Q2 24 | 45.1% | 54.6% |
营业利润率FASTSOLV
| Q1 26 | 18.9% | — | ||
| Q4 25 | 18.9% | 6.3% | ||
| Q3 25 | 20.7% | 80.6% | ||
| Q2 25 | 21.0% | 9.9% | ||
| Q1 25 | 20.1% | 7.3% | ||
| Q4 24 | 18.9% | 6.6% | ||
| Q3 24 | 20.3% | 13.2% | ||
| Q2 24 | 20.2% | 11.7% |
净利率FASTSOLV
| Q1 26 | 14.5% | — | ||
| Q4 25 | 14.5% | 3.2% | ||
| Q3 25 | 15.7% | 60.4% | ||
| Q2 25 | 15.9% | 4.2% | ||
| Q1 25 | 15.2% | 6.6% | ||
| Q4 24 | 14.4% | 1.5% | ||
| Q3 24 | 15.6% | 5.9% | ||
| Q2 24 | 15.3% | 4.3% |
每股收益（稀释后）FASTSOLV
| Q1 26 | $-0.01 | — | ||
| Q4 25 | $-0.01 | $0.37 | ||
| Q3 25 | $0.29 | $7.22 | ||
| Q2 25 | $0.29 | $0.51 | ||
| Q1 25 | $0.52 | $0.78 | ||
| Q4 24 | $0.45 | $0.18 | ||
| Q3 24 | $0.52 | $0.70 | ||
| Q2 24 | $0.51 | $0.51 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $276.8M | $878.0M |
| 总债务越低越好 | $125.0M | $5.0B |
| 股东权益账面价值 | $3.9B | $5.0B |
| 总资产 | $5.1B | $14.3B |
| 负债/权益比越低杠杆越低 | 0.03× | 1.00× |
8季度趋势，按日历期对齐
现金及短期投资FASTSOLV
| Q1 26 | $276.8M | — | ||
| Q4 25 | $276.8M | $878.0M | ||
| Q3 25 | $288.1M | $1.6B | ||
| Q2 25 | $237.8M | $492.0M | ||
| Q1 25 | $231.8M | $534.0M | ||
| Q4 24 | $255.8M | $762.0M | ||
| Q3 24 | $292.2M | $772.0M | ||
| Q2 24 | $255.5M | $897.0M |
总债务FASTSOLV
| Q1 26 | $125.0M | — | ||
| Q4 25 | $125.0M | $5.0B | ||
| Q3 25 | $195.0M | $5.1B | ||
| Q2 25 | $230.0M | $7.8B | ||
| Q1 25 | $200.0M | $7.9B | ||
| Q4 24 | $200.0M | $8.0B | ||
| Q3 24 | $240.0M | $8.1B | ||
| Q2 24 | $235.0M | $8.3B |
股东权益FASTSOLV
| Q1 26 | $3.9B | — | ||
| Q4 25 | $3.9B | $5.0B | ||
| Q3 25 | $3.9B | $5.0B | ||
| Q2 25 | $3.8B | $3.6B | ||
| Q1 25 | $3.7B | $3.3B | ||
| Q4 24 | $3.6B | $3.0B | ||
| Q3 24 | $3.6B | $3.2B | ||
| Q2 24 | $3.5B | $2.9B |
总资产FASTSOLV
| Q1 26 | $5.1B | — | ||
| Q4 25 | $5.1B | $14.3B | ||
| Q3 25 | $5.1B | $14.0B | ||
| Q2 25 | $5.0B | $15.1B | ||
| Q1 25 | $4.9B | $14.5B | ||
| Q4 24 | $4.7B | $14.5B | ||
| Q3 24 | $4.7B | $14.7B | ||
| Q2 24 | $4.6B | $14.6B |
负债/权益比FASTSOLV
| Q1 26 | 0.03× | — | ||
| Q4 25 | 0.03× | 1.00× | ||
| Q3 25 | 0.05× | 1.03× | ||
| Q2 25 | 0.06× | 2.14× | ||
| Q1 25 | 0.05× | 2.43× | ||
| Q4 24 | 0.06× | 2.71× | ||
| Q3 24 | 0.07× | 2.54× | ||
| Q2 24 | 0.07× | 2.90× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $368.2M | $95.0M |
| 自由现金流经营现金流 - 资本支出 | $308.2M | $32.0M |
| 自由现金流率自由现金流/营收 | 15.2% | 1.6% |
| 资本支出强度资本支出/营收 | 3.0% | 3.2% |
| 现金转化率经营现金流/净利润 | 1.25× | 1.51× |
| 过去12个月自由现金流最近4个季度 | $1.2B | $-10.0M |
8季度趋势，按日历期对齐
经营现金流FASTSOLV
| Q1 26 | $368.2M | — | ||
| Q4 25 | $368.2M | $95.0M | ||
| Q3 25 | $386.9M | $76.0M | ||
| Q2 25 | $278.6M | $169.0M | ||
| Q1 25 | $262.2M | $29.0M | ||
| Q4 24 | $282.8M | $219.0M | ||
| Q3 24 | $296.9M | $169.0M | ||
| Q2 24 | $258.0M | $355.0M |
自由现金流FASTSOLV
| Q1 26 | $308.2M | — | ||
| Q4 25 | $308.2M | $32.0M | ||
| Q3 25 | $326.6M | $-21.0M | ||
| Q2 25 | $209.3M | $59.0M | ||
| Q1 25 | $206.5M | $-80.0M | ||
| Q4 24 | $222.6M | $92.0M | ||
| Q3 24 | $237.5M | $76.0M | ||
| Q2 24 | $201.9M | $297.0M |
自由现金流率FASTSOLV
| Q1 26 | 15.2% | — | ||
| Q4 25 | 15.2% | 1.6% | ||
| Q3 25 | 15.3% | -1.0% | ||
| Q2 25 | 10.1% | 2.7% | ||
| Q1 25 | 10.5% | -3.9% | ||
| Q4 24 | 12.2% | 4.4% | ||
| Q3 24 | 12.4% | 3.7% | ||
| Q2 24 | 10.5% | 14.3% |
资本支出强度FASTSOLV
| Q1 26 | 3.0% | — | ||
| Q4 25 | 3.0% | 3.2% | ||
| Q3 25 | 2.8% | 4.6% | ||
| Q2 25 | 3.3% | 5.1% | ||
| Q1 25 | 2.8% | 5.3% | ||
| Q4 24 | 3.3% | 6.1% | ||
| Q3 24 | 3.1% | 4.5% | ||
| Q2 24 | 2.9% | 2.8% |
现金转化率FASTSOLV
| Q1 26 | 1.25× | — | ||
| Q4 25 | 1.25× | 1.51× | ||
| Q3 25 | 1.15× | 0.06× | ||
| Q2 25 | 0.84× | 1.88× | ||
| Q1 25 | 0.88× | 0.21× | ||
| Q4 24 | 1.08× | 7.06× | ||
| Q3 24 | 1.00× | 1.39× | ||
| Q2 24 | 0.88× | 3.99× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FAST
| Reportable Segment Aggregation Before Other Operating Segment | $1.8B | 90% |
| Other | $211.2M | 10% |
SOLV
| Infection Prevention And Surgical Solutions | $752.0M | 38% |
| Cost Of Software And Rentals | $508.0M | 25% |
| Health Information Systems Segment | $347.0M | 17% |
| Dental Solutions Segment | $343.0M | 17% |
| Related Party | $14.0M | 1% |
